Xbrane Biopharma AB Financial Overview
Xbrane Biopharma AB's market cap is currently €28.18M. The company's EPS TTM is €; its P/E ratio is 0.04; Xbrane Biopharma AB is scheduled to report earnings on October 24, 2025, and the estimated EPS forecast is €0.15. See an overview of income statement, balance sheet, and cash flow financials.